Chimerix Inc Banner Image

Chimerix Inc

  • Ticker CMRX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Chimerix Inc Logo Image
  • 51-200 Employees
  • Based in Durham, North Carolina
Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral antivirals to address unmet medical needs in the United States. The company’s lead compounds include brincidofovir (CMX001), an oral nucleotide analog that is in Phase III clinical trial for the prevention of cytomegalovirus (CMV) in adult hematopoietic cell transplant recipients, as well as to treatMore adenovirus infection; and CMX157, a nucleotide analog for the treatment of HIV and hepatitis B virus infections. Its preclinical testing product includes CMX669 for the treatment of BK virus and CMV.
4.7 / 5.0 (138)

Chimerix Inc reports have an aggregate usefulness score of 4.7 based on 138 reviews.

Chimerix Inc

Most Recent Annual Report

Chimerix Inc
MOST RECENT 2023 Annual Report and Form 10K

Chimerix Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Chimerix Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!